Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, NetBio Partner on DNA Products for Forensics Space

NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and NetBio said on Monday they will commercialize new products for DNA sample collection and analysis for the forensics market.

The partnership allies the global distribution reach and sample collection capabilities of GE Healthcare Life Sciences, a business unit of GE Healthcare, with NetBio's DNA analysis technologies. The deal will result in products that make DNA fingerprinting easier and quicker than with current methods, the partners said.

James Schumm, vice president of molecular biology for NetBio, said that his firm's technology combines a large number of complex DNA process steps "into a fully automated, fully integrated system for rapid DNA analysis."

DNA analysis has revolutionized forensics, he added, and "partnering with GE Healthcare has the potential to accelerate the pace of this revolution by commercializing products that will provide law enforcement agencies and forensic laboratories with faster results."

Financial and other terms of the deal were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.